1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.2.1 INCLUSIONS & EXCLUSIONS 25
1.3 STUDY SCOPE 25
1.3.1 MARKETS COVERED 25
1.3.2 GEOGRAPHICAL SEGMENTATION 26
1.4 YEARS CONSIDERED 26
1.5 CURRENCY 27
1.6 RESEARCH LIMITATIONS 27
1.7 STAKEHOLDERS 27
1.8 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 1 MULTIMODAL IMAGING MARKET: RESEARCH DESIGN 29
2.1.1 SECONDARY RESEARCH 30
2.1.2 PRIMARY RESEARCH 31
2.1.2.1 Primary sources 32
2.1.2.2 Key industry insights 33
2.1.2.3 Breakdown of primaries 34
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 34
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.2 MARKET SIZE ESTIMATION 35
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 36
2.2.1 BOTTOM-UP APPROACH 36
2.2.1.1 Approach 1: Company revenue estimation approach 36
FIGURE 5 MARKET SIZE ESTIMATION FOR MULTIMODAL IMAGING: APPROACH 1 (COMPANY REVENUE ESTIMATION) 37
FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF SIEMENS HEALTHINEERS 38
2.2.1.2 Approach 2: Customer-based market estimation 38
2.2.1.3 Multimodal imaging market: Top-down approach 39
2.2.1.4 Approach 3: CAGR projections 39
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39
2.3 DATA TRIANGULATION 40
FIGURE 8 DATA TRIANGULATION METHODOLOGY 40
2.4 MARKET SHARE ASSESSMENT 41
2.5 STUDY ASSUMPTIONS 41
2.6 GROWTH RATE ASSUMPTIONS 42
2.7 RISK ASSESSMENT 42
2.7.1 MULTIMODAL IMAGING MARKET: RISK ASSESSMENT 42
2.8 RECESSION IMPACT 42
3 EXECUTIVE SUMMARY 44
FIGURE 9 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 44
FIGURE 10 MULTIMODAL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 45
FIGURE 11 MULTIMODAL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 46
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF MULTIMODAL IMAGING MARKET 47
4 PREMIUM INSIGHTS 48
4.1 MULTIMODAL IMAGING MARKET OVERVIEW 48
FIGURE 13 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES TO DRIVE MARKET 48
4.2 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 49
FIGURE 14 PET/CT MULTIMODAL IMAGING SYSTEMS TO DOMINATE NORTH AMERICAN MARKET IN 2023 49
4.3 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 50
FIGURE 15 HOSPITALS TO DOMINATE ASIA PACIFIC MARKET IN 2023 50
4.4 EUROPE: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 51
FIGURE 16 ONCOLOGY SEGMENT TO DOMINATE EUROPEAN MARKET DURING FORECAST PERIOD 51
4.5 MULTIMODAL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52
FIGURE 17 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 54
FIGURE 18 MULTIMODAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
5.2.1 DRIVERS 54
5.2.1.1 Growing applications of multimodal imaging systems 54
5.2.1.2 Technological advancements in diagnostic imaging modalities 55
TABLE 1 TECHNOLOGICAL ADVANCEMENTS IN MULTIMODAL IMAGING SYSTEMS 55
5.2.1.3 Availability of funding for research 57
5.2.1.4 Increasing establishment of hospitals and diagnostic imaging centers 58
5.2.2 RESTRAINTS 58
5.2.2.1 Unfavorable healthcare reforms 58
5.2.2.2 High capital and operational cost 59
5.2.2.3 Lack of adequate healthcare infrastructure 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Availability of reimbursement and insurance coverage for scans 59
TABLE 2 CODES FOR SPECT/CT FUSION IMAGING (AS OF 2021) 60
TABLE 3 NATIONAL PET, PET/CT COVERAGE FOR ONCOLOGY (AS OF 2021) 60
5.2.3.2 Increasing R&D into radiotracers 61
5.2.4 CHALLENGES 61
5.2.4.1 Growing end-user preference for refurbished equipment 61
5.2.4.2 Dearth of trained professionals 62
5.3 PORTER’S FIVE FORCES ANALYSIS 62
TABLE 4 MULTIMODAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 62
5.3.1 THREAT OF NEW ENTRANTS 62
5.3.2 THREAT OF SUBSTITUTES 63
5.3.3 BARGAINING POWER OF SUPPLIERS 63
5.3.4 BARGAINING POWER OF BUYERS 63
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 63
5.4 REGULATORY TRENDS 63
5.4.1 REGULATORY TRENDS FOR MULTIMODAL IMAGING MARKET 63
5.5 REGULATORY ANALYSIS 64
5.5.1 NORTH AMERICA 64
5.5.1.1 US 64
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION 64
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 65
5.5.1.2 Canada 65
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 65
5.5.2 EUROPE 66
5.5.3 ASIA PACIFIC 66
5.5.3.1 Japan 66
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 67
5.5.3.2 China 67
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES 67
5.5.3.3 India 68
5.6 REIMBURSEMENT SCENARIO 69
TABLE 10 MEDICAL REIMBURSEMENT CPT CODES FOR MULTIMODAL IMAGING PROCEDURES IN US (AS OF 2021) 69
5.7 ECOSYSTEM MAPPING 70
5.8 VALUE CHAIN ANALYSIS 70
5.8.1 RESEARCH & PRODUCT DEVELOPMENT 70
5.8.2 RAW MATERIAL AND MANUFACTURING 71
5.8.3 MARKETING & SALES, SHIPMENT, AND POST-SALES SERVICES 71
FIGURE 19 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE 71
5.9 SUPPLY CHAIN ANALYSIS 72
5.9.1 PROMINENT COMPANIES 72
5.9.2 SMALL AND MEDIUM-SIZED ENTERPRISES 72
5.9.3 END USERS 72
TABLE 11 MULTIMODAL IMAGING MARKET: SUPPLY CHAIN ECOSYSTEM 72
FIGURE 20 MULTIMODAL IMAGING MARKET: SUPPLY CHAIN ANALYSIS 73
5.10 PATENT ANALYSIS 74
FIGURE 21 PATENTS FOR PET/CT IMAGING SYSTEMS (JANUARY 2013–JULY 2023) 74
FIGURE 22 PATENTS FOR PET/MR IMAGING SYSTEMS (JANUARY 2013–JULY 2023) 75
FIGURE 23 PATENTS FOR SPECT/CT IMAGING SYSTEMS (JANUARY 2013–JULY 2023) 76
FIGURE 24 PATENTS FOR OCT IMAGING SYSTEMS (JANUARY 2013–JULY 2023) 77
5.11 TRADE ANALYSIS 78
5.11.1 MULTIMODAL IMAGING MARKET: TRADE ANALYSIS 78
TABLE 12 IMPORT DATA FOR MULTIMODAL IMAGING (HS CODE 901820), BY COUNTRY, 2018–2022 (USD) 78
TABLE 13 EXPORT DATA FOR MULTIMODAL IMAGING (HS CODE 901820), BY COUNTRY, 2018–2022 (USD) 78
5.12 KEY CONFERENCES AND EVENTS 79
TABLE 14 MULTIMODAL IMAGING MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023–2025) 79
5.13 TECHNOLOGY ANALYSIS 80
5.14 CASE STUDY ANALYSIS 81
TABLE 15 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE 81
TABLE 16 CASE STUDY 2: PROVIDING COMPREHENSIVE TRAINING PROGRAMS FOR EVOLVING MULTIMODAL IMAGING TECHNIQUES 82
5.15 PRICING ANALYSIS 82
TABLE 17 REGION-WISE PRICE RANGE FOR MULTIMODAL IMAGING SYSTEMS 82
6 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY 83
6.1 INTRODUCTION 84
TABLE 18 MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 84
6.2 PET/CT SYSTEMS 84
6.2.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH 84
TABLE 19 PET/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 85
TABLE 20 PET/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 86
TABLE 21 PET/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021–2028 (USD MILLION) 86
6.3 SPECT/CT SYSTEMS 87
6.3.1 INCREASING APPLICATIONS OF SPECT/CT SYSTEMS TO DRIVE MARKET 87
TABLE 22 SPECT/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 23 SPECT/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 88
TABLE 24 SPECT/CT MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021–2028 (USD MILLION) 89
6.4 PET/MR SYSTEMS 89
6.4.1 ADVANTAGES OFFERED OVER PET/CT SYSTEMS FOR DIAGNOSTIC PURPOSES TO PROPEL MARKET 89
TABLE 25 PET/MR MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 90
TABLE 26 PET/MR MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 91
TABLE 27 PET/MR MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021–2028 (USD MILLION) 91
6.5 OCT/FMT SYSTEMS 92
6.5.1 INCREASING APPLICATIONS IN RETINAL DISEASE DIAGNOSIS TO DRIVE MARKET 92
TABLE 28 OCT/FMT MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 92
TABLE 29 OCT/FMT MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 93
TABLE 30 OCT/FMT MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021–2028 (USD MILLION) 93
6.6 OTHER MULTIMODAL IMAGING SYSTEMS 94
TABLE 31 OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 32 OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 95
TABLE 33 OTHER MULTIMODAL IMAGING SYSTEMS MARKET, BY END USER, 2021–2028 (USD MILLION) 95
7 MULTIMODAL IMAGING MARKET, BY APPLICATION 96
7.1 INTRODUCTION 97
TABLE 34 MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 97
7.2 ONCOLOGY 97
7.2.1 INCREASING DEMAND FOR EARLY AND ACCURATE CANCER DIAGNOSIS TO DRIVE MARKET 97
TABLE 35 MULTIMODAL IMAGING MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 98
7.3 CARDIOLOGY 98
7.3.1 RISING PREVALENCE OF CARDIAC DISORDERS TO DRIVE GROWTH 98
TABLE 36 MULTIMODAL IMAGING MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 99
7.4 OPHTHALMOLOGY 100
7.4.1 TECHNOLOGICAL INNOVATIONS IN OPHTHALMIC MULTIMODAL IMAGING SYSTEMS TO SUPPORT MARKET GROWTH 100
TABLE 37 MULTIMODAL IMAGING MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 101
7.5 BRAIN & NEUROLOGY 101
7.5.1 INCREASING INCIDENCE OF BRAIN & NEUROLOGICAL DISORDERS TO PROPEL ADOPTION OF MULTIMODAL IMAGING SYSTEMS 101
TABLE 38 MULTIMODAL IMAGING MARKET FOR BRAIN & NEUROLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 102
7.6 RESEARCH 102
7.6.1 CAPABILITY TO PROVIDE COMPREHENSIVE AND SYNERGISTIC INSIGHTS INTO COMPLEX PHENOMENA TO SUPPORT MARKET GROWTH 102
TABLE 39 MULTIMODAL IMAGING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 103
7.7 OTHER APPLICATIONS 103
TABLE 40 MULTIMODAL IMAGING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 104
8 MULTIMODAL IMAGING MARKET, BY END USER 105
8.1 INTRODUCTION 106
TABLE 41 MULTIMODAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 106
8.2 HOSPITALS 106
8.2.1 HIGH PROCEDURAL VOLUMES TO ENSURE SUSTAINED DEMAND FOR MULTIMODAL IMAGING 106
TABLE 42 MULTIMODAL IMAGING MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 107
8.3 DIAGNOSTIC IMAGING CENTERS 107
8.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO SUPPORT MARKET GROWTH 107
TABLE 43 MULTIMODAL IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2021–2028 (USD MILLION) 108
8.4 ACADEMIC & RESEARCH INSTITUTES 108
8.4.1 GROWING AVAILABILITY OF RESEARCH GRANTS AND FUNDING TO DRIVE MARKET 108
TABLE 44 MULTIMODAL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 109
8.5 OTHER END USERS 109
TABLE 45 MULTIMODAL IMAGING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 110
9 MULTIMODAL IMAGING MARKET, BY REGION 111
9.1 INTRODUCTION 112
TABLE 46 MULTIMODAL IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION) 112
9.2 NORTH AMERICA 112
9.2.1 RECESSION IMPACT 112
FIGURE 25 NORTH AMERICA: MULTIMODAL IMAGING MARKET SNAPSHOT 113
TABLE 47 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 48 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 114
TABLE 49 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 115
TABLE 50 NORTH AMERICA: MULTIMODAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 115
9.2.2 US 116
9.2.2.1 Rising geriatric population to drive market 116
TABLE 51 US: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 117
9.2.3 CANADA 117
9.2.3.1 Government investments to support market growth 117
TABLE 52 CANADA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 118
9.3 EUROPE 118
9.3.1 RECESSION IMPACT 118
TABLE 53 EUROPE: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 54 EUROPE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 119
TABLE 55 EUROPE: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 120
TABLE 56 EUROPE: MULTIMODAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 120
9.3.2 GERMANY 121
9.3.2.1 Increasing prevalence of chronic diseases to drive market 121
TABLE 57 GERMANY: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 121
9.3.3 FRANCE 122
9.3.3.1 Rising number of diagnostic imaging centers to propel market 122
TABLE 58 FRANCE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 122
9.3.4 UK 123
9.3.4.1 Government initiatives to support market growth 123
TABLE 59 UK: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 123
9.3.5 ITALY 124
9.3.5.1 Availability of reimbursement coverage to support market growth 124
TABLE 60 ITALY: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 124
9.3.6 SPAIN 125
9.3.6.1 Increasing public funding for cell-based research to propel market 125
TABLE 61 SPAIN: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 125
9.3.7 REST OF EUROPE 126
TABLE 62 REST OF EUROPE: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 126
9.4 ASIA PACIFIC 127
9.4.1 RECESSION IMPACT 127
FIGURE 26 ASIA PACIFIC: MULTIMODAL IMAGING MARKET SNAPSHOT 128
TABLE 63 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 64 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 129
TABLE 65 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 130
TABLE 66 ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 130
9.4.2 CHINA 131
9.4.2.1 Rapidly growing geriatric population to propel market 131
TABLE 67 CHINA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 131
9.4.3 JAPAN 132
9.4.3.1 High adoption of advanced technologies to support market growth 132
TABLE 68 JAPAN: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 132
9.4.4 INDIA 133
9.4.4.1 Rising prevalence of various chronic diseases to drive market 133
TABLE 69 INDIA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 133
9.4.5 AUSTRALIA 134
9.4.5.1 Increasing investments in research to provide opportunities for market growth 134
TABLE 70 AUSTRALIA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 134
9.4.6 SOUTH KOREA 135
9.4.6.1 Presence of well-developed healthcare system to propel market 135
TABLE 71 SOUTH KOREA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 135
9.4.7 REST OF ASIA PACIFIC 135
TABLE 72 REST OF ASIA PACIFIC: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 136
9.5 LATIN AMERICA 136
9.5.1 RECESSION IMPACT 136
TABLE 73 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 74 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 137
TABLE 75 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138
TABLE 76 LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 138
9.5.2 BRAZIL 139
9.5.2.1 Favorable demographic conditions to drive market 139
TABLE 77 BRAZIL: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 139
9.5.3 MEXICO 140
9.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market 140
TABLE 78 MEXICO: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 140
9.5.4 REST OF LATIN AMERICA 141
TABLE 79 REST OF LATIN AMERICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 141
9.6 MIDDLE EAST & AFRICA 142
9.6.1 GROWING MEDICAL TOURISM TO DRIVE MARKET 142
9.6.2 RECESSION IMPACT 142
TABLE 80 MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 143
TABLE 81 MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 143
TABLE 82 MIDDLE EAST & AFRICA: MULTIMODAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 144
10 COMPETITIVE LANDSCAPE 145
10.1 OVERVIEW 145
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 145
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MULTIMODAL IMAGING MARKET 145
10.3 REVENUE SHARE ANALYSIS 146
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN MULTIMODAL IMAGING MARKET, 2020–2022 146
10.4 MARKET SHARE ANALYSIS 147
FIGURE 28 MARKET SHARE ANALYSIS OF TOP PLAYERS IN MULTIMODAL IMAGING MARKET, 2022 147
TABLE 83 MULTIMODAL IMAGING MARKET: DEGREE OF COMPETITION 147
10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 149
10.5.1 STARS 149
10.5.2 EMERGING LEADERS 149
10.5.3 PERVASIVE PLAYERS 149
10.5.4 PARTICIPANTS 149
FIGURE 29 MULTIMODAL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 150
10.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 151
10.6.1 PROGRESSIVE COMPANIES 151
10.6.2 STARTING BLOCKS 151
10.6.3 RESPONSIVE COMPANIES 151
10.6.4 DYNAMIC COMPANIES 151
FIGURE 30 MULTIMODAL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022 152
10.7 COMPETITIVE BENCHMARKING 153
TABLE 84 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF COMPANIES 153
TABLE 85 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES 154
TABLE 86 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES 155
10.8 COMPETITIVE SCENARIO AND TRENDS 156
TABLE 87 PRODUCT LAUNCHES, JANUARY 2020–JULY 2023 156
TABLE 88 DEALS, JANUARY 2020–JULY 2023 157
TABLE 89 OTHER DEVELOPMENTS, JANUARY 2020–JULY 2023 158
11 COMPANY PROFILES 160
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
11.1 KEY PLAYERS 160
11.1.1 GE HEALTHCARE 160
TABLE 90 GE HEALTHCARE: COMPANY OVERVIEW 160
FIGURE 31 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 161
11.1.2 KONINKLIJKE PHILIPS N.V. 166
TABLE 91 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 166
FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 167
11.1.3 CANON MEDICAL SYSTEMS CORPORATION 170
TABLE 92 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 170
FIGURE 33 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2022) 171
11.1.4 SIEMENS HEALTHINEERS 174
TABLE 93 SIEMENS HEALTHINEERS: COMPANY OVERVIEW 174
FIGURE 34 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022) 175
11.1.5 ZEISS GROUP 178
TABLE 94 ZEISS GROUP: COMPANY OVERVIEW 178
FIGURE 35 CARL ZEISS MEDITEC GROUP: COMPANY SNAPSHOT (2022) 179
11.1.6 BRUKER 182
TABLE 95 BRUKER: COMPANY OVERVIEW 182
FIGURE 36 BRUKER: COMPANY SNAPSHOT (2022) 183
11.1.7 MEDISO LTD. 185
TABLE 96 MEDISO LTD.: COMPANY OVERVIEW 185
11.1.8 NEUSOFT CORPORATION. 187
TABLE 97 NEUSOFT CORPORATION: COMPANY OVERVIEW 187
11.1.9 INFRAREDX, INC. (PART OF NIPRO CORPORATION) 190
TABLE 98 INFRAREDX, INC.: COMPANY OVERVIEW 190
FIGURE 38 NIPRO CORPORATION: COMPANY SNAPSHOT (2022) 191
11.1.10 TOPCON CORPORATION 192
TABLE 99 TOPCON CORPORATION: COMPANY OVERVIEW 192
FIGURE 39 TOPCON CORPORATION: COMPANY SNAPSHOT (2022) 193
11.1.11 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. 195
TABLE 100 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW 195
11.1.12 HEIDELBERG ENGINEERING 198
TABLE 101 HEIDELBERG ENGINEERING: COMPANY OVERVIEW 198
11.1.13 SPECTRUM DYNAMICS MEDICAL 200
TABLE 102 SPECTRUM DYNAMICS MEDICAL: COMPANY OVERVIEW 200
11.1.14 MINFOUND MEDICAL SYSTEMS CO., LTD. 202
TABLE 103 MINFOUND MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW 202
11.1.15 KINDSWAY BIOTECH 204
TABLE 104 KINDSWAY BIOTECH: COMPANY OVERVIEW 204
11.2 OTHER COMPANIES 205
11.2.1 SOFIE BIOSCIENCES, INC. 205
11.2.2 REFLEXION MEDICAL, INC. 205
11.2.3 CUBRESA INC. 206
11.2.4 FUJIFILM CORPORATION 206
11.2.5 POSITRON 207
11.2.6 MR SOLUTIONS 208
11.2.7 ALCON INC. 209
11.2.8 ESSILOR INSTRUMENTS USA 209
11.2.9 NIDEK CO., LTD. 210
11.2.10 ZIEMER OPHTHALMIC SYSTEMS AG 210
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 211
12.1 DISCUSSION GUIDE 211
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 214
12.3 CUSTOMIZATION OPTIONS 216
12.4 RELATED REPORTS 216
12.5 AUTHOR DETAILS 217
世界のマルチモーダルイメージング市場（～2028年）：技術別（PET-CT、SPECT-CT、PET-MR、OCT/FMT）、用途別（腫瘍学、心臓病学、脳、眼科）、エンドユーザー別（病院、診断センター、学術、研究）、地域別 |
| 【英語タイトル】Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT/FMT), Application (Oncology, Cardiology, Brain, Ophthalmology), End User (Hospitals, Diagnostic Centers, Academia, Research) & Region - Global Forecast to 2028 | |
 | ・商品コード：MD7353-23 ・発行会社（調査会社）：MarketsandMarkets ・発行日：2023年9月10日 ・ページ数：213 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後24時間以内） ・調査対象地域：グローバル ・産業分野：医療機器 |
| Single User（1名様閲覧） | USD4,950 ⇒換算￥722,700 | 見積依頼/購入/質問フォーム |
| Multi User (Five User) | USD6,650 ⇒換算￥970,900 | 見積依頼/購入/質問フォーム |
| Corporate License (全社内共有可) | USD8,150 ⇒換算￥1,189,900 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| "世界のマルチモーダルイメージング市場は、2023年の42億米ドルから2028年には55億米ドルに達し、2023年から2028年までの年平均成長率は5.7％と予測" 対象疾患の罹患率/有病率の高さ、画像診断センター/処置数の増加、疾患の早期診断の利点に関する意識の高まり、技術的に先進的な画像診断システム、機能、モダリティの急速な採用などの要因が、この市場の成長を増大させています。 "2022年、技術セグメントのPET-CTセグメントが市場で最大シェアを獲得" 技術に基づき、マルチモーダルイメージング市場はPET-CT、PET/MR、SPECT-CT、OCT/FMT、その他のマルチモーダルイメージングに区分されます 。PET-CTセグメントが市場の主要シェアを占めています。PET検査とCT検査を1回で行うことにより、被ばく線量と検査時間を低減し、臨床的汎用性は腫瘍学、循環器学、神経学、感染症など多岐にわたります。初期費用はかかりますが、診断の向上、追加検査の必要性の減少、研究の進歩により、PET-CTの費用対効果が現れ、患者の転帰と医学研究に大きな利益をもたらす価値あるツールとなっていることが、この製品セグメントの成長を牽引しています。 "予測期間中に最も高いCAGRを記録すると予測される腫瘍分野" アプリケーションに基づき、マルチモーダルイメージング市場は脳・神経学、心臓学、腫瘍学、眼科学、研究およびその他のアプリケーションに区分されます。2022年に最大の市場シェアを占めたのは腫瘍学分野でした。このセグメントの大きなシェアは、システムの多用途性、画質、高度化、使いやすい機能、病院や医療機関における急性期医療や救急医療での使用増加によるものです。 "エンドユーザー別の画像診断センターセグメントは予測期間中に大きなCAGRを記録すると予測" エンドユーザー別に見ると、マルチモーダルイメージング市場は病院、画像診断センター、学術・研究機関に区分されます。2022年のマルチモーダルイメージング市場で最大のシェアを占めたのは画像診断センター部門でした。画像診断センターは、PET-CT、MRI-PET、SPECT-CTなどの複数の画像モダリティを統合することで、より正確で信頼性の高い診断を提供することができ、より良い治療計画と患者の転帰の改善につながります。さらに、マルチモーダル画像診断の汎用性により、これらのセンターは幅広い診療科目に対応することができ、多様な医療ニーズを持つ患者に効果的にサービスを提供することができます。 "予測期間中、北米地域の市場が最も高い成長を遂げる見込み" 北米地域のマルチモーダルイメージング市場は、予測期間中にCAGRを記録することが期待されており、その主な理由は、同地域における高い医療支出、対象疾患の有病率の上昇、研究活動の増加、美容整形手術の増加、イメージングシステムの技術進歩などです。 本レポートで参照した主な参入企業の内訳は以下の通りです： - 企業タイプ別 ティア1-48％、ティア2-36％、ティア3-16％ - 役職別 ディレクターレベル-14％、Cレベル-10％、その他-76％ - 地域別 北米-40％、ヨーロッパ-32％、アジア太平洋-20％、中南米-5％、中東・アフリカ-3％ マルチモーダルイメージング市場の主要企業は、GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Siemens AG (Germany), Neusoft (China), Topcon Corporation (Japan), and Bruker (US)などが含まれます。 調査範囲： この調査レポートは、マルチモーダルイメージング市場を技術、ディスプレイ、携帯性、コンポーネント、用途、エンドユーザー、地域に基づいて調査しています。また、市場成長に影響を与える要因を網羅し、市場における様々な機会と課題を分析し、市場リーダーのための競争環境の詳細を提供します。さらに、ミクロ市場の成長動向を分析し、主要5地域（およびこれらの地域の各国）に関する市場セグメントの収益を予測しています。 レポート購入の理由： 本レポートは、マルチモーダルイメージング市場全体とサブセグメントに関する収益数字の最も近い近似値に関する情報を提供し、市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得ることで、事業の位置づけを高め、適切な市場参入戦略を計画するのに役立ちます。また、本レポートは、関係者が市場の脈動を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供するのに役立ちます。 本レポートは、以下のポイントに関する洞察を提供します： - マルチモーダルイメージング市場の成長に影響を与える主な促進要因（対象患者数の増加、マルチモーダル画像診断装置の採用拡大、技術進歩、官民組織による投資・資金・助成金の増加）、阻害要因（資本コストおよび運用コストの高さ、不利な規制ガイドライン）、機会（新興国における医療インフラの改善、乳房画像診断におけるPETの利用、有望な製品パイプライン）、課題（代替画像診断技術の利用可能性）の分析を行っています。 - 製品開発/イノベーション：マルチモーダルイメージング市場における今後の技術、研究開発活動、新製品・サービス開始に関する詳細な洞察を掲載しています。 - 市場開発：有利な市場に関する包括的情報-様々な地域のマルチモーダルイメージング市場を分析しています。 - 市場の多様化：マルチモーダルイメージング市場における新製品、未開拓地域、最近の開発、投資に関する詳細情報を提供します。 - 競合評価：GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Siemens AG (Germany), Neusoft (China), Topcon Corporation (Japan), and Bruker (US)などの主要企業の市場シェア、成長戦略、サービス内容を詳細に評価しています。 |
1.イントロダクション
2.調査方法
3.エグゼクティブサマリー
4.プレミアムインサイト
5.市場概要
6.マルチモーダルイメージングの市場分析：技術別
7.マルチモーダルイメージングの市場分析：用途別
8.マルチモーダルイメージングの市場分析：エンドユーザー別
9.マルチモーダルイメージングの市場分析：地域別
10.競争状況
11.企業情報
12.付録
❖ レポートの目次 ❖
| ★調査レポート[世界のマルチモーダルイメージング市場（～2028年）：技術別（PET-CT、SPECT-CT、PET-MR、OCT/FMT）、用途別（腫瘍学、心臓病学、脳、眼科）、エンドユーザー別（病院、診断センター、学術、研究）、地域別] (コード：MD7353-23)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のマルチモーダルイメージング市場（～2028年）：技術別（PET-CT、SPECT-CT、PET-MR、OCT/FMT）、用途別（腫瘍学、心臓病学、脳、眼科）、エンドユーザー別（病院、診断センター、学術、研究）、地域別]についてメールでお問い合わせ |
